AAAAAA

   
Results: 1-12 |
Results: 12
Herpes simplex virus DNA vaccine efficacy: Effect of glycoprotein D plasmid constructs
Authors: Strasser, JE Arnold, RL Pachuk, C Higgins, TJ Bernstein, DI
Citation: Je. Strasser et al., Herpes simplex virus DNA vaccine efficacy: Effect of glycoprotein D plasmid constructs, J INFEC DIS, 182(5), 2000, pp. 1304-1310
Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses
Authors: Higgins, TJ Herold, KM Arnold, RL McElhiney, SP Shroff, KE Pachuk, CJ
Citation: Tj. Higgins et al., Plasmid DNA-expressed secreted and nonsecreted forms of herpes simplex virus glycoprotein D2 induce different types of immune responses, J INFEC DIS, 182(5), 2000, pp. 1311-1320
Vaccination of seronegative volunteers with a human immunodeficiency virustype 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines
Authors: Boyer, JD Cohen, AD Vogt, S Schumann, K Nath, B Ahn, L Lacy, K Bagarazzi, ML Higgins, TJ Baine, Y Ciccarelli, RB Ginsberg, RS MacGregor, RR Weiner, DB
Citation: Jd. Boyer et al., Vaccination of seronegative volunteers with a human immunodeficiency virustype 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines, J INFEC DIS, 181(2), 2000, pp. 476-483
Serum immunoglobulin G (IgG) and IgG subclass responses to the RgpA-Kgp proteinase-adhesin complex of Porphyromonas gingivalis in adult periodontitis
Authors: O'Brien-Simpson, NM Black, CL Bhogal, PS Cleal, SM Slakeski, N Higgins, TJ Reynolds, EC
Citation: Nm. O'Brien-simpson et al., Serum immunoglobulin G (IgG) and IgG subclass responses to the RgpA-Kgp proteinase-adhesin complex of Porphyromonas gingivalis in adult periodontitis, INFEC IMMUN, 68(5), 2000, pp. 2704-2712
Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine
Authors: Pachuk, CJ Ciccarelli, RB Samuel, M Bayer, ME Troutman, RD Zurawski, DV Schauer, JI Higgins, TJ Weiner, DB Sosnoski, DM Zurawski, VR Satishchandran, C
Citation: Cj. Pachuk et al., Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine, BBA-BIOMEMB, 1468(1-2), 2000, pp. 20-30
Enhancement of cellular immune response in HIV-1 seropositive individuals:A DNA-based trial
Authors: Boyer, JD Chattergoon, MA Ugen, KE Shah, A Bennett, M Cohen, A Nyland, S Lacy, KE Bagarazzi, ML Higgins, TJ Baine, Y Ciccarelli, RB Ginsberg, RS MacGregor, RR Weiner, DB
Citation: Jd. Boyer et al., Enhancement of cellular immune response in HIV-1 seropositive individuals:A DNA-based trial, CLIN IMMUNO, 90(1), 1999, pp. 100-107
Potential for plasmid DNAs as vaccines for the new millennium
Authors: Shroff, KE Smith, LR Baine, Y Higgins, TJ
Citation: Ke. Shroff et al., Potential for plasmid DNAs as vaccines for the new millennium, PHARM SCI T, 2(5), 1999, pp. 205-212
Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration
Authors: Shroff, KE Marcucci-Borges, LA de Bruin, SJ Winter, LA Tiberio, L Pachuk, C Snyder, LA Satishchandran, C Ciccarelli, RB Higgins, TJ
Citation: Ke. Shroff et al., Induction of HSV-gD2 specific CD4(+) cells in Peyer's patches and mucosal antibody responses in mice following DNA immunization by both parenteral and mucosal administration, VACCINE, 18(3-4), 1999, pp. 222-230
Evaluating transportation programs: Neglected principles
Authors: Higgins, TJ Johnson, WL
Citation: Tj. Higgins et Wl. Johnson, Evaluating transportation programs: Neglected principles, TRANSPORTAT, 26(4), 1999, pp. 323-336
In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model
Authors: Sin, JI Kim, JJ Boyer, JD Ciccarelli, RB Higgins, TJ Weiner, DB
Citation: Ji. Sin et al., In vivo modulation of vaccine-induced immune responses toward a Th1 phenotype increases potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model, J VIROLOGY, 73(1), 1999, pp. 501-509
IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge. (vol 162, pg 2912, 1999)
Authors: Sin, JI Kim, JJ Arnold, RL Shroff, KE McCallus, D Pachuk, C McElhiney, SP Wolf, MW Pompa-de Bruin, SJ Higgins, TJ Ciccarelli, RB Weiner, DB
Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge. (vol 162, pg 2912, 1999), J IMMUNOL, 163(2), 1999, pp. 1094-1094
IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge
Authors: Sin, JI Kim, JJ Arnold, RL Shroff, KE McCallus, D Pachuk, C McElhiney, SP Wolf, MW Pompa-de Bruin, SJ Higgins, TJ Ciccarelli, RB Weiner, DB
Citation: Ji. Sin et al., IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4(+) T cell-mediated protective immunity against herpes simplex virus-2 challenge, J IMMUNOL, 162(5), 1999, pp. 2912-2921
Risultati: 1-12 |